Amir Garakani

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi request reprint Neurobiology of anxiety disorders and implications for treatment
    Amir Garakani
    Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 73:941-9. 2006
  2. doi request reprint Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    J Affect Disord 146:262-5. 2013
  3. pmc The effect of doxapram on brain imaging in patients with panic disorder
    Amir Garakani
    Laboratory of Clinical Psychobiology, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
    Eur Neuropsychopharmacol 17:672-86. 2007
  4. doi request reprint Effect of medication and psychotherapy on heart rate variability in panic disorder
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Depress Anxiety 26:251-8. 2009
  5. doi request reprint Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients
    Jose M Martinez
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Psychosom Med 72:442-9. 2010
  6. doi request reprint Proinflammatory and "resiliency" proteins in the CSF of patients with major depression
    Jose M Martinez
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    Depress Anxiety 29:32-8. 2012
  7. doi request reprint The pharmacological treatment of bipolar disorder: the question of modern advances
    Jack Hirschowitz
    Department of Psychiatry, Mount Sinai School of Medicine, USA
    Harv Rev Psychiatry 18:266-78. 2010
  8. doi request reprint Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists
    John H Krystal
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 24:669-93. 2010
  9. doi request reprint Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study
    Sanjay J Mathew
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Ther 30:1658-66. 2008
  10. doi request reprint A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10075, USA
    Int Clin Psychopharmacol 23:269-75. 2008

Detail Information

Publications11

  1. ncbi request reprint Neurobiology of anxiety disorders and implications for treatment
    Amir Garakani
    Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 73:941-9. 2006
    ..Combining these medication approaches with psychotherapies that promote extinction, such as cognitive behavioral therapy (CBT), may offer patients with anxiety disorders a rapid and robust treatment with good durability of effect...
  2. doi request reprint Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    J Affect Disord 146:262-5. 2013
    ..The goal of this study was to compare the CSF levels of glutamate, glutamine and CRH between patients with depression and healthy controls...
  3. pmc The effect of doxapram on brain imaging in patients with panic disorder
    Amir Garakani
    Laboratory of Clinical Psychobiology, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
    Eur Neuropsychopharmacol 17:672-86. 2007
    ..This suggests that panic disorder patients activate frontal inhibitory centers less than controls, a tendency that may lower the threshold for panic...
  4. doi request reprint Effect of medication and psychotherapy on heart rate variability in panic disorder
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Depress Anxiety 26:251-8. 2009
    ..Low HRV has been associated with elevated risk for cardiovascular disease. Our aim was to investigate the effects of treatment on heart rate (HR) in patients with PD through a hyperventilation challenge...
  5. doi request reprint Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients
    Jose M Martinez
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Psychosom Med 72:442-9. 2010
    ....
  6. doi request reprint Proinflammatory and "resiliency" proteins in the CSF of patients with major depression
    Jose M Martinez
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    Depress Anxiety 29:32-8. 2012
    ....
  7. doi request reprint The pharmacological treatment of bipolar disorder: the question of modern advances
    Jack Hirschowitz
    Department of Psychiatry, Mount Sinai School of Medicine, USA
    Harv Rev Psychiatry 18:266-78. 2010
    ..The purpose of this review is to examine the evidence for treatments that were available in 1970 and to determine if the field has made any significant advance in the treatment of mania, bipolar depression, and maintenance...
  8. doi request reprint Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists
    John H Krystal
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 24:669-93. 2010
    ..This review also links growing insights into the role of glutamate in the pathophysiology of these disorders to hypothesized mGluR-related treatment mechanisms...
  9. doi request reprint Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study
    Sanjay J Mathew
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Ther 30:1658-66. 2008
    ..The serotonin 1A (5-hydroxytryptamine 1A [5-HT1A]) receptor likely plays a critical role in anxiety pathophysiology...
  10. doi request reprint A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    Amir Garakani
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10075, USA
    Int Clin Psychopharmacol 23:269-75. 2008
    ..The combination of quetiapine and fluoxetine, however, improved sleep over fluoxetine alone over the first few weeks of treatment...
  11. ncbi request reprint Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder
    Randall D Marshall
    Anxiety Disorders Clinic, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Psychiatr Clin North Am 25:385-95. 2002
    ....